Radius Ventures

Center for Elders' Independence Signs with TRHC for Key PACE Services

Retrieved on: 
Tuesday, November 8, 2022
Organization, Elder, Center, NASDAQ, Pharmacy, CMS, Patient, CEI, Radius Ventures, Interim, PACE, Medicare, Centers for Medicare & Medicaid Services, View, Solution, Program, Multimedia, Risk, Safety, CEO, Health insurance, Pharmaceutical industry

MOORESTOWN, N.J., Nov. 8, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced that the Center for Elders' Independence (CEI), a California PACE program of 30 years and one of the largest in the nation, has signed a three year agreement with TRHC for key PACE (Program of All-Inclusive Care for the Elderly) services, including comprehensive pharmacy and risk adjustment services to support their five centers and more than 1,000 participants in the East San Francisco Bay area.

Key Points: 
  • "We are thrilled to partner with CEI to enhance the participant experience and PACE outcomes," said Brian Adams, President and Interim CEO of TRHC.
  • "Our commitment to optimizing organizational outcomes for PACE has helped us become a trusted partner for PACE organizations at every phase of development."
  • CEI implemented TRHC's Capstone Risk Adjustment services in June of 2022 and completed implementation of CareKinesis PACE-specific pharmacy services on November 1st, 2022.
  • Tabula Rasa HealthCare (TRHC) (NASDAQ: TRHC) provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combating medication overload and reducing adverse drug events.

TRHC's Clinical Advisory Panel Meeting Provides Insights on PACE Pharmacy

Retrieved on: 
Wednesday, September 21, 2022
Science, MD, Pharmacy, Program, Patient, MBA, Pharmacist, Interim, Solution, CAP, NASDAQ, Research, Multimedia, Radius Ventures, View, Death, Healthcare, Medicine

Attendees included Program of All-Inclusive Care for the Elderly (PACE) medical directors from across the country and featured educational sessions related to PACE pharmacy.

Key Points: 
  • Attendees included Program of All-Inclusive Care for the Elderly (PACE) medical directors from across the country and featured educational sessions related to PACE pharmacy.
  • "TRHC's CAP Meeting provides an opportunity to bring together medical directors from some of the leading PACE programs in the country to share insights and learn about findings from PACE-related research," said Brian Adams, President and Interim CEO of TRHC.
  • TRHC offers pharmacogenomic analysis from clinical pharmacists through the medication risk mitigation services its CareKinesis PACE Pharmacy provides.
  • "Pharmacogenomic analysis can help PACE programs enhance pharmacotherapy, and we see great promise in implementing pharmacogenomics in PACE."

New Study Demonstrates Benefit of Advanced Decision Support in Driving Pharmacist Recommendations to Reduce Medication Risk

Retrieved on: 
Tuesday, August 16, 2022
Death, Journal of the American Geriatrics Society, Multimedia, Radius Ventures, Risk, CEO, Dementia, Science, Antagonist, Falls, Pharmacy, Research, American Geriatrics Society, Patient, PACE, View, ALS Therapy Development Institute, Delirium, Doctor of Philosophy, NASDAQ, Bachelor of Pharmacy, Journal, Solution, Urinary incontinence, Program, Organization, Pharmacist, Medicine, Pharmaceutical industry

MOORESTOWN, N.J., Aug. 16, 2022 /PRNewswire/ -- A new peer-reviewed study from Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, shows that pharmacist recommendations driven by its unique medication decision support system, MedWise® Science, can help prescribers identify and reduce the levels of potentially inappropriate medications among older adults, reducing the risk of negative cognitive and physical outcomes.

Key Points: 
  • The study, published in the Journal of the American Geriatrics Society, explored the dosage levels of urinary antimuscarinic medications with high anticholinergic properties.
  • MedWise Science uses the active ingredients from a participant's complete medication list, including over-the-counter drugs, to identify the risk of simultaneous, accumulative, multi-drug interactions, and predict the possibility of medication problems.
  • The research involved participants from 35 PACE organizations that use TRHC's comprehensive CareKinesis PACE Pharmacy and medication risk mitigation services.
  • TRHC offers comprehensive clinical pharmacy services for PACE organizations that provide ongoing medication assessments, comprehensive safety reviews, medication risk mitigation interventions, pharmacogenomic application, 24/7 medication management support, and adherence packaging, among other benefits.

Simcha Therapeutics Accelerates Growth with Key Leadership Appointments, Expanded Research and Option Agreement with Yale School of Medicine

Retrieved on: 
Tuesday, August 16, 2022
Oncology, Health, Clinical Trials, Research, Science, Biotechnology, Sequah Medicine Company, LIFE, Beatrice, Thomas Jefferson University, ATyr Pharma, CEO, Internal medicine, Wuxi, Cancer, SVKM's NMIMS, Thomas Jefferson University Hospital, Yale School of Medicine, Research, Kellogg School, Patient, Therapy, Company, Amgen, Skin, Bauer, PPD, Cytokine, Iron ring (laboratory), Radius Ventures, Organization, RNA transfection, Management, Pharmaceutical industry, Simcha, Medicine, Pfizer, Northwestern University

Simcha has also expanded its sponsored research agreement with Yale School of Medicine related to cytokine biology in the laboratory of Aaron Ring, Ph.D., M.D., associate professor of immunobiology and Simcha founder.

Key Points: 
  • Simcha has also expanded its sponsored research agreement with Yale School of Medicine related to cytokine biology in the laboratory of Aaron Ring, Ph.D., M.D., associate professor of immunobiology and Simcha founder.
  • Through this expanded agreement, the company will support research in the Ring Laboratory focused on overcoming biological limitations of native cytokines.
  • Simcha holds an exclusive option to license multiple therapeutic agents resulting from the expanded research agreement.
  • Simcha Therapeutics is a clinical-stage immunobiology company pioneering the development of first-in-class engineered cytokine therapeutics with transformational promise for patients.

Tabula Rasa HealthCare Announces Partnership Extension with Gary and Mary West PACE

Retrieved on: 
Tuesday, March 29, 2022
Risk, Organization, Pharmacy, NASDAQ, Death, Multimedia, Doctor of Pharmacy, Program, MPA, Medi-Cal, Radius Ventures, CA, MBA, PACE, Solution, Patient, Healthcare, Hospital, Medicare

MOORESTOWN, N.J., March 29, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced a five-year renewal with Gary and Mary West PACE for its CareKinesis PACE Pharmacy and Pharmastar services. Gary and Mary West PACE is a Program of All-inclusive Care for the Elderly (PACE) in San Marcos, CA, which currently serves over 180 participants who live in North County San Diego. TRHC has partnered with Gary and Mary West PACE since 2018, with the program holding its official opening in October 2019.

Key Points: 
  • (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced a five-year renewal with Gary and Mary West PACE for its CareKinesis PACE Pharmacy and Pharmastar services.
  • Gary and Mary West PACE is a Program of All-inclusive Care for the Elderly (PACE) in San Marcos, CA, which currently serves over 180 participants who live in North County San Diego.
  • TRHC has partnered with Gary and Mary West PACE since 2018, with the program holding its official opening in October 2019.
  • To apply or learn more about eligibility, contact Gary and Mary West PACE at (760) 280-2230 or visit their website at www.westpace.org .

New Study Further Validates Cost Savings from Unique Medication Risk Mitigation Technology

Retrieved on: 
Thursday, March 17, 2022
Doctor of Philosophy, MD, Quality of life, Solution, Health care, Patient, Death, Health, Disulfiram-like drug, Pharmacy, PACE, Multimedia, Organization, Radius Ventures, Risk, Science, Pace Center for Girls, NASDAQ, ADE, Pharmacist, View, Technology, Nursing, Pharmaceutical industry, Health insurance

MOORESTOWN, N.J., March 17, 2022 /PRNewswire/ -- Technology that uses simultaneous, accumulative, multi-drug interactions to identify potential medication risk has been proven to improve patients' health and well-being. Now, a new study published in the journal Healthcare from Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, demonstrates that identifying the risk of multi-drug interactions, before they occur, can significantly reduce healthcare costs for Programs of All-Inclusive Care for the Elderly (PACE). 

Key Points: 
  • CareKinesis uses TRHC's MedWise Science to identify patients at high risk for Adverse Drug Events (ADE), including emergency room visits, re-hospitalizations and falls.
  • Certified MedWise Advisor pharmacists provide actionable insights in the form of pharmacist recommendations, prior to the medication being dispensed.
  • The CareKinesis medication risk mitigation system analyzes the potential for drugs to interact simultaneously.
  • "The study, which included over 2,500 participants from 19 PACE organizations, shows the economic value of advanced medication risk mitigation services," said Alan Stein, MD PhD, TRHC, SVP Healthcare Analytics.

PACE Executives Summit Highlights Opportunity for Market Growth and Trends in Participant Care

Retrieved on: 
Wednesday, December 1, 2021
Patient, United States Senate Special Committee on Aging, Doctor of Pharmacy, CEO, Elder, Senate, Technology, Ageing, Death, Medicare, Radius Ventures, Organization, MBA, Program, Solution, Director, PACE, Center, View, Tablet, Multimedia, NASDAQ, Growth, Trinity Health, Pharmacy, National, Health insurance, Management

"The PACE Plus Act aims to help existing PACE sites grow by removing barriers to enrollment and development," Baker added.

Key Points: 
  • "The PACE Plus Act aims to help existing PACE sites grow by removing barriers to enrollment and development," Baker added.
  • "The act also aims to foster new PACE operations, with the potential to create significant opportunities for older adults to join PACE."
  • The opportunity for growth was a recurring theme of the CareVention HealthCare summit.
  • "PACE organizations represented at the summit reported heightened attention to home-based care," said TRHC Co-Founder and President, Orsula V. Knowlton, PharmD, MBA.

Tabula Rasa HealthCare Announces Five-Year Contract Extension with Rocky Mountain PACE

Retrieved on: 
Monday, November 15, 2021
PACE, View, Pharmacy, Centers for Medicare & Medicaid Services, CMS, Medicare, NASDAQ, MBA, Growth, Multimedia, Radius Ventures, Program, Partnership, Human, RPM, Solution, Center, Death, RMP, Time, Rocky Mountains, Doctor of Pharmacy, Risk, Patient, Health insurance, Healthcare

MOORESTOWN, N.J., Nov. 15, 2021 /PRNewswire/ --Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced a five-year contract renewal with Rocky Mountain PACE (RMP), a Program of All-Inclusive Care for the Elderly (PACE) sponsored by Rocky Mountain Health Care Services of Colorado serving more than 800 participants in Colorado Springs.

Key Points: 
  • MOORESTOWN, N.J., Nov. 15, 2021 /PRNewswire/ --Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced a five-year contract renewal with Rocky Mountain PACE (RMP), a Program of All-Inclusive Care for the Elderly (PACE) sponsored by Rocky Mountain Health Care Services of Colorado serving more than 800 participants in Colorado Springs.
  • As they expand their program, Rocky Mountain PACE will continue to rely on TRHC 's CareKinesis pharmacy and personalized medication management services.
  • "We have been thrilled with the results we have seen from partnering with CareKinesis," said Ann Kjosa, Executive Vice President of Rocky Mountain Health Care Services.
  • "We are pleased Rocky Mountain PACE is continuing this long-term partnership," said TRHC President Orsula V. Knowlton, PharmD, MBA.

Neighborhood Healthcare Selects Tabula Rasa Healthcare for PACE-Centered Pharmacy Solutions

Retrieved on: 
Wednesday, September 22, 2021
FQHC, Program of All-Inclusive Care for the Elderly, Program, Pharmacy, Solution, Health, CPE, NASDAQ, Multimedia, Patient, Radius Ventures, MD, Doctor of Pharmacy, FAAFP, CEO, Happiness, Death, PACE, Growth, Professional, MBA, View, Federally Qualified Health Center, PBM, Health insurance, Healthcare, Management

"As a new PACE center, we place medication safety as a top priority," said Sophia Rodrigues, Executive Director of Neighborhood Healthcare PACE.

Key Points: 
  • "As a new PACE center, we place medication safety as a top priority," said Sophia Rodrigues, Executive Director of Neighborhood Healthcare PACE.
  • Along with Pharmastar's full-service pharmacy benefits management solution, these offerings will provide Neighborhood Healthcare with PACE-specific 340B pharmacy expertise.
  • "We're pleased to implement TRHC's solutions in our PACE offerings," added Rakesh Patel, MD, MBA, FAAFP, CPE, CEO of Neighborhood Healthcare.
  • Tabula Rasa HealthCare (TRHC) (NASDAQ: TRHC) provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combatting medication overload and reducing adverse drug events the fourth leading cause of death in the US.

CareVention HealthCare Inks Shared Service Deal with PACE Association of Michigan

Retrieved on: 
Monday, August 30, 2021
Center, Program, Centers for Medicare & Medicaid Services, Technology, Radius Ventures, CMS, Association, Pharmacy, Financial management, Solution, Medicare, Health, Death, Medication, EHR, PACE, Multimedia, MBA, NASDAQ, Safety, Risk, PAM, Program of All-Inclusive Care for the Elderly, Patient, Partnership, Health information management, Organization, Doctor of Pharmacy, View, Health insurance, Healthcare

MOORESTOWN, N.J., Aug. 30, 2021 /PRNewswire/ -- CareVention HealthCare, a division of Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), today announced a new shared partnership agreement with the PACE Association of Michigan (PAM).

Key Points: 
  • MOORESTOWN, N.J., Aug. 30, 2021 /PRNewswire/ -- CareVention HealthCare, a division of Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), today announced a new shared partnership agreement with the PACE Association of Michigan (PAM).
  • "CareVention HealthCare and its service lines have outstanding reputations in the PACE community," said Stephanie Winslow, Executive Director of PAM.
  • In Michigan, 100% of PACE organizations already partner with CareVention HealthCare for at least one service.
  • CareVention HealthCare service lines include CareKinesis PACE Pharmacy, Capstone Risk Adjustment Services, PeakTPA, CareVention EHR/Integrated Technology Solutions, and CareVention Consulting.